These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

92 related articles for article (PubMed ID: 219269)

  • 21. Phase II evaluation of dianhydrogalactitol in the treatment of advanced endometrial adenocarcinoma: a Gynecologic Oncology Group Study.
    Stehman FB; Blessing JA; Delgado G; Louka M
    Cancer Treat Rep; 1983; 67(7-8):737-8. PubMed ID: 6871892
    [No Abstract]   [Full Text] [Related]  

  • 22. In vivo synchronization and cell kinetics-directed treatment scheduled in human tumor therapy.
    Barranco SC; Townsend CM; Costanzi JJ; Guseman LF
    Prog Clin Biol Res; 1983; 132C():163-70. PubMed ID: 6634770
    [No Abstract]   [Full Text] [Related]  

  • 23. Preoperative radiotherapy and chemotherapy in hypervascular, high-grade supratentorial astrocytomas.
    Seiler RW; Zimmermann A; Bleher EA; Markwalder H
    Surg Neurol; 1979 Aug; 12(2):131-3. PubMed ID: 229577
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Phase II study of the combination of dianhydrogalactitol, doxorubicin, and cisplatin (DAP) in patients with advanced squamous cell lung cancer.
    Eagan RT; Frytak S; Nichols WC; Ingle JN; Creagan ET; Kvols LK
    Cancer Treat Rep; 1981; 65(5-6):517-9. PubMed ID: 7195306
    [No Abstract]   [Full Text] [Related]  

  • 25. Dianhydrogalactitol and neural tumors: an in vitro, in vivo preclinical evaluation.
    Helson L; Rozsa P; Hajdu E; Helson JL
    Cancer Treat Rep; 1980; 64(12):1287-94. PubMed ID: 7471118
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Phase II evaluation of galactitol in head and neck cancer: a Southwest Oncology Group Study.
    Haas CD; Lehane D; Bottomley R
    Med Pediatr Oncol; 1983; 11(4):281-3. PubMed ID: 6888328
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Development and some characteristics of a P388 leukemia strain resistant to 1, 2:5, 6-dianhydrogalactitol.
    Bence J; Somfai-Relle S; Gáti E
    Eur J Cancer Clin Oncol; 1986 Jul; 22(7):773-80. PubMed ID: 3770035
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Clinical and pharmacologic evaluation of split-dose intermittent therapy with dianhydrogalactitol.
    Eagan RT; Ames MM; Powis G; Kovach JS
    Cancer Treat Rep; 1982 Feb; 66(2):283-7. PubMed ID: 7034934
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Adjuvant chemotherapy with VM 26 and CCNU after operation and radiotherapy of high-grade supratentorial astrocytomas.
    Seiler RW; Zimmermann A; Markwalder H
    Surg Neurol; 1980 Jan; 13(1):65-8. PubMed ID: 6244679
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Phase I and II studies of cytostatic hexitol derivatives: the role of alkylating metabolites?
    Eckhardt S; Kerpel-Fronius S; Horváth IP; Institoris L
    Gan To Kagaku Ryoho; 1985 Mar; 12(3 Pt 2):783-8. PubMed ID: 3985644
    [No Abstract]   [Full Text] [Related]  

  • 31. Effect of phase I and II chemotherapeutic agents against human lymphomas heterotransplanted in nude mice.
    Sordillo PP; Helson C; Lesser M; Helson L
    Oncology; 1983; 40(1):15-7. PubMed ID: 6823403
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Phase II Radiation Therapy Oncology Group trial of conventional radiation therapy followed by treatment with recombinant interferon-beta for supratentorial glioblastoma: results of RTOG 9710.
    Colman H; Berkey BA; Maor MH; Groves MD; Schultz CJ; Vermeulen S; Nelson DF; Mehta MP; Yung WK;
    Int J Radiat Oncol Biol Phys; 2006 Nov; 66(3):818-24. PubMed ID: 16887285
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Combined modality therapy of operated astrocytomas grade III and IV. Confirmation of the value of postoperative irradiation and lack of potentiation of bleomycin on survival time: a prospective multicenter trial of the Scandinavian Glioblastoma Study Group.
    Kristiansen K; Hagen S; Kollevold T; Torvik A; Holme I; Nesbakken R; Hatlevoll R; Lindgren M; Brun A; Lindgren S; Notter G; Andersen AP; Elgen K
    Cancer; 1981 Feb; 47(4):649-52. PubMed ID: 6164465
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Phase II trial of galactitol 1,2:5,6-dianhydro (NSC 132313) in the treatment of advanced gynecologic malignancies: a Gynecologic Oncology Group study.
    Stehman FB; Blom J; Blessing JA; Ehrlich CE; Mangan C
    Gynecol Oncol; 1983 Jun; 15(3):381-90. PubMed ID: 6862293
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Perturbed cell kinetics of 9L rat brain tumor cells following dianhydrogalactitol.
    Nomura K; Hoshino T; Deen DF; Knebel KD
    Cancer Treat Rep; 1978 Dec; 62(12):2055-61. PubMed ID: 751715
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Phase II studies of dianhydrogalactitol and VP-16-213 in colorectal cancer.
    Perry MC; Moertel CG; Schutt AJ; Reitemeier RJ; Hahn RG
    Cancer Treat Rep; 1976 Sep; 60(9):1247-50. PubMed ID: 797447
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Adjuvant therapy in the treatment of malignant glioma.
    Kim RY; Langford KH; Roth RE
    J Med Assoc State Ala; 1977 Oct; 47(4):39-41. PubMed ID: 200689
    [No Abstract]   [Full Text] [Related]  

  • 38. Phase III randomized study of postradiotherapy chemotherapy with alpha-difluoromethylornithine-procarbazine, N-(2-chloroethyl)-N'-cyclohexyl-N-nitrosurea, vincristine (DFMO-PCV) versus PCV for glioblastoma multiforme.
    Levin VA; Uhm JH; Jaeckle KA; Choucair A; Flynn PJ; Yung WKA ; Prados MD; Bruner JM; Chang SM; Kyritsis AP; Gleason MJ; Hess KR
    Clin Cancer Res; 2000 Oct; 6(10):3878-84. PubMed ID: 11051233
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Use of 1,2:5,6-dianhydrogalactitol in studies on cell kinetics-directed chemotherapy schedules in human tumors in vivo.
    Barranco SC; Townsend CM; Costanzi JJ; May JT; Baltz R; O'Quinn AG; Leipzig B; Hokanson KM; Guseman LF; Boerwinkle WR
    Cancer Res; 1982 Jul; 42(7):2899-2905. PubMed ID: 7083178
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Neuro-Oncology Working Group 01 trial of nimustine plus teniposide versus nimustine plus cytarabine chemotherapy in addition to involved-field radiotherapy in the first-line treatment of malignant glioma.
    Weller M; Müller B; Koch R; Bamberg M; Krauseneck P;
    J Clin Oncol; 2003 Sep; 21(17):3276-84. PubMed ID: 12947063
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.